Report Detail

Pharma & Healthcare Global Non-opioid Pain Patches Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4595855
  • |
  • 12 June, 2024
  • |
  • Global
  • |
  • 113 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Non-opioid Pain Patches market size was valued at USD 649.7 million in 2023 and is forecast to a readjusted size of USD 771.6 million by 2030 with a CAGR of 2.5% during review period.
The Global Info Research report includes an overview of the development of the Non-opioid Pain Patches industry chain, the market status of Hospital Pharmacies (Lidocaine Patch, Diclofenac Patch), Independent Pharmacies & Drug Stores (Lidocaine Patch, Diclofenac Patch), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-opioid Pain Patches.
Regionally, the report analyzes the Non-opioid Pain Patches markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-opioid Pain Patches market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Non-opioid Pain Patches market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-opioid Pain Patches industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Lidocaine Patch, Diclofenac Patch).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-opioid Pain Patches market.
Regional Analysis: The report involves examining the Non-opioid Pain Patches market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-opioid Pain Patches market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Non-opioid Pain Patches:
Company Analysis: Report covers individual Non-opioid Pain Patches manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-opioid Pain Patches This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Independent Pharmacies & Drug Stores).
Technology Analysis: Report covers specific technologies relevant to Non-opioid Pain Patches. It assesses the current state, advancements, and potential future developments in Non-opioid Pain Patches areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-opioid Pain Patches market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Non-opioid Pain Patches market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
Market segment by Application
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
Major players covered
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-opioid Pain Patches product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-opioid Pain Patches, with price, sales, revenue and global market share of Non-opioid Pain Patches from 2019 to 2024.
Chapter 3, the Non-opioid Pain Patches competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-opioid Pain Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Non-opioid Pain Patches market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-opioid Pain Patches.
Chapter 14 and 15, to describe Non-opioid Pain Patches sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Non-opioid Pain Patches
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Non-opioid Pain Patches Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Lidocaine Patch
    • 1.3.3 Diclofenac Patch
    • 1.3.4 Methyl Salicylate Patch
    • 1.3.5 Capsaicin Patch
    • 1.3.6 Ketoprofen Patch
    • 1.3.7 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Non-opioid Pain Patches Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Independent Pharmacies & Drug Stores
    • 1.4.4 Online Pharmacies
  • 1.5 Global Non-opioid Pain Patches Market Size & Forecast
    • 1.5.1 Global Non-opioid Pain Patches Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Non-opioid Pain Patches Sales Quantity (2019-2030)
    • 1.5.3 Global Non-opioid Pain Patches Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Non-opioid Pain Patches Product and Services
    • 2.1.4 Pfizer Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 GlaxoSmithKline
    • 2.2.1 GlaxoSmithKline Details
    • 2.2.2 GlaxoSmithKline Major Business
    • 2.2.3 GlaxoSmithKline Non-opioid Pain Patches Product and Services
    • 2.2.4 GlaxoSmithKline Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 GlaxoSmithKline Recent Developments/Updates
  • 2.3 Johnson & Johnson
    • 2.3.1 Johnson & Johnson Details
    • 2.3.2 Johnson & Johnson Major Business
    • 2.3.3 Johnson & Johnson Non-opioid Pain Patches Product and Services
    • 2.3.4 Johnson & Johnson Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Johnson & Johnson Recent Developments/Updates
  • 2.4 Novartis AG
    • 2.4.1 Novartis AG Details
    • 2.4.2 Novartis AG Major Business
    • 2.4.3 Novartis AG Non-opioid Pain Patches Product and Services
    • 2.4.4 Novartis AG Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Novartis AG Recent Developments/Updates
  • 2.5 Mylan N.V.
    • 2.5.1 Mylan N.V. Details
    • 2.5.2 Mylan N.V. Major Business
    • 2.5.3 Mylan N.V. Non-opioid Pain Patches Product and Services
    • 2.5.4 Mylan N.V. Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Mylan N.V. Recent Developments/Updates
  • 2.6 Teva Pharmaceutical Industries
    • 2.6.1 Teva Pharmaceutical Industries Details
    • 2.6.2 Teva Pharmaceutical Industries Major Business
    • 2.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Product and Services
    • 2.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
  • 2.7 Hisamitsu Pharmaceutical
    • 2.7.1 Hisamitsu Pharmaceutical Details
    • 2.7.2 Hisamitsu Pharmaceutical Major Business
    • 2.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Product and Services
    • 2.7.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Hisamitsu Pharmaceutical Recent Developments/Updates
  • 2.8 TEH SENG Pharmaceutical
    • 2.8.1 TEH SENG Pharmaceutical Details
    • 2.8.2 TEH SENG Pharmaceutical Major Business
    • 2.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Product and Services
    • 2.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 TEH SENG Pharmaceutical Recent Developments/Updates
  • 2.9 Teikoku Seiyaku
    • 2.9.1 Teikoku Seiyaku Details
    • 2.9.2 Teikoku Seiyaku Major Business
    • 2.9.3 Teikoku Seiyaku Non-opioid Pain Patches Product and Services
    • 2.9.4 Teikoku Seiyaku Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Teikoku Seiyaku Recent Developments/Updates
  • 2.10 IBSA Institut Biochimque SA
    • 2.10.1 IBSA Institut Biochimque SA Details
    • 2.10.2 IBSA Institut Biochimque SA Major Business
    • 2.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Product and Services
    • 2.10.4 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 IBSA Institut Biochimque SA Recent Developments/Updates
  • 2.11 Acorda Therapeutics
    • 2.11.1 Acorda Therapeutics Details
    • 2.11.2 Acorda Therapeutics Major Business
    • 2.11.3 Acorda Therapeutics Non-opioid Pain Patches Product and Services
    • 2.11.4 Acorda Therapeutics Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Acorda Therapeutics Recent Developments/Updates
  • 2.12 Allergan PLC
    • 2.12.1 Allergan PLC Details
    • 2.12.2 Allergan PLC Major Business
    • 2.12.3 Allergan PLC Non-opioid Pain Patches Product and Services
    • 2.12.4 Allergan PLC Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Allergan PLC Recent Developments/Updates
  • 2.13 Endo International
    • 2.13.1 Endo International Details
    • 2.13.2 Endo International Major Business
    • 2.13.3 Endo International Non-opioid Pain Patches Product and Services
    • 2.13.4 Endo International Non-opioid Pain Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Endo International Recent Developments/Updates

3 Competitive Environment: Non-opioid Pain Patches by Manufacturer

  • 3.1 Global Non-opioid Pain Patches Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Non-opioid Pain Patches Revenue by Manufacturer (2019-2024)
  • 3.3 Global Non-opioid Pain Patches Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Non-opioid Pain Patches by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Non-opioid Pain Patches Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Non-opioid Pain Patches Manufacturer Market Share in 2023
  • 3.5 Non-opioid Pain Patches Market: Overall Company Footprint Analysis
    • 3.5.1 Non-opioid Pain Patches Market: Region Footprint
    • 3.5.2 Non-opioid Pain Patches Market: Company Product Type Footprint
    • 3.5.3 Non-opioid Pain Patches Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Non-opioid Pain Patches Market Size by Region
    • 4.1.1 Global Non-opioid Pain Patches Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Non-opioid Pain Patches Consumption Value by Region (2019-2030)
    • 4.1.3 Global Non-opioid Pain Patches Average Price by Region (2019-2030)
  • 4.2 North America Non-opioid Pain Patches Consumption Value (2019-2030)
  • 4.3 Europe Non-opioid Pain Patches Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Non-opioid Pain Patches Consumption Value (2019-2030)
  • 4.5 South America Non-opioid Pain Patches Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Non-opioid Pain Patches Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Non-opioid Pain Patches Sales Quantity by Type (2019-2030)
  • 5.2 Global Non-opioid Pain Patches Consumption Value by Type (2019-2030)
  • 5.3 Global Non-opioid Pain Patches Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Non-opioid Pain Patches Sales Quantity by Application (2019-2030)
  • 6.2 Global Non-opioid Pain Patches Consumption Value by Application (2019-2030)
  • 6.3 Global Non-opioid Pain Patches Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Non-opioid Pain Patches Sales Quantity by Type (2019-2030)
  • 7.2 North America Non-opioid Pain Patches Sales Quantity by Application (2019-2030)
  • 7.3 North America Non-opioid Pain Patches Market Size by Country
    • 7.3.1 North America Non-opioid Pain Patches Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Non-opioid Pain Patches Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Non-opioid Pain Patches Sales Quantity by Type (2019-2030)
  • 8.2 Europe Non-opioid Pain Patches Sales Quantity by Application (2019-2030)
  • 8.3 Europe Non-opioid Pain Patches Market Size by Country
    • 8.3.1 Europe Non-opioid Pain Patches Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Non-opioid Pain Patches Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Non-opioid Pain Patches Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Non-opioid Pain Patches Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Non-opioid Pain Patches Market Size by Region
    • 9.3.1 Asia-Pacific Non-opioid Pain Patches Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Non-opioid Pain Patches Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Non-opioid Pain Patches Sales Quantity by Type (2019-2030)
  • 10.2 South America Non-opioid Pain Patches Sales Quantity by Application (2019-2030)
  • 10.3 South America Non-opioid Pain Patches Market Size by Country
    • 10.3.1 South America Non-opioid Pain Patches Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Non-opioid Pain Patches Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Non-opioid Pain Patches Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Non-opioid Pain Patches Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Non-opioid Pain Patches Market Size by Country
    • 11.3.1 Middle East & Africa Non-opioid Pain Patches Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Non-opioid Pain Patches Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Non-opioid Pain Patches Market Drivers
  • 12.2 Non-opioid Pain Patches Market Restraints
  • 12.3 Non-opioid Pain Patches Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Non-opioid Pain Patches and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Non-opioid Pain Patches
  • 13.3 Non-opioid Pain Patches Production Process
  • 13.4 Non-opioid Pain Patches Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Non-opioid Pain Patches Typical Distributors
  • 14.3 Non-opioid Pain Patches Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Non-opioid Pain Patches. Industry analysis & Market Report on Non-opioid Pain Patches is a syndicated market report, published as Global Non-opioid Pain Patches Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Non-opioid Pain Patches market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,651.76
    3,977.64
    5,303.52
    3,138.96
    4,708.44
    6,277.92
    490,540.80
    735,811.20
    981,081.60
    292,180.80
    438,271.20
    584,361.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report